Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Tracking resistance results presented at Westminster

The APPG on Malaria & NTDs gathered on Tuesday, March 19th in Westminster at the Houses of Parliament.

Jeremy Lefroy MP welcomed Rob van der Pluijm on behalf of the Mahidol-Oxford Tropical Medicine Research Unit (MORU), the Tracking Resistance to Artemesinin Collaboration II and the Developing Triple Artemisinin-based Combination Therapies (DeTACT) Project.

Read the full article

Similar stories

Oxford University and Brazil Ministry of Health Sign Letter of Intent to Strengthen Cancer Care Across Brazil

The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data

Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness

Dr. Yi-Ling Chen (COI) awarded prestigious ERC Starting Grant

Nigeria rolls out new Oxford R21 malaria vaccine

Developing the first cancer prevention vaccine for Lynch syndrome